|
Services hospitaliers partagés américains (AMS): Business Model Canvas [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
American Shared Hospital Services (AMS) Bundle
Dans le paysage dynamique de la technologie des soins de santé, les services hospitaliers partagés américains (AMS) apparaissent comme une force pionnière, révolutionnant l'accès aux équipements médicaux et les services de radiation. En pontant stratégiquement la technologie de pointe avec les besoins critiques des établissements de soins de santé, AMS offre des solutions innovantes qui transforment la façon dont les hôpitaux acquièrent, utilisent et maintiennent des équipements médicaux de pointe. Leur toile de modèle commercial unique révèle une approche sophistiquée pour relever des défis complexes de l'infrastructure des soins de santé, offrant des services de technologie médicale rentables et de haute qualité qui permettent aux prestataires de soins de santé de se concentrer sur les soins aux patients tout en minimisant les risques d'investissement en capital.
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: partenariats clés
Fabricants et fournisseurs d'équipements médicaux
AMS s'associe aux fabricants d'équipements médicaux suivants:
| Fabricant | Type d'équipement | Valeur du contrat annuel |
|---|---|---|
| GE Healthcare | Scanners IRM et CT | 12,4 millions de dollars |
| Siemens Healthineers | Équipement de radiothérapie | 8,7 millions de dollars |
| Philips Healthcare | Systèmes d'imagerie diagnostique | 6,2 millions de dollars |
Sociétés de technologie de santé
Les partenariats technologiques clés comprennent:
- Systèmes épiques - Intégration des dossiers de santé électroniques
- Cerner Corporation - Solutions de logiciels de santé
- Cisco Systems - Infrastructure réseau
Hôpitaux et centres médicaux du pays
| Région | Nombre d'hôpitaux partenaires | Revenus de partenariat annuel |
|---|---|---|
| Nord-est | 37 | 22,1 millions de dollars |
| Midwest | 42 | 19,8 millions de dollars |
| Côte ouest | 28 | 16,5 millions de dollars |
| Sud | 33 | 17,3 millions de dollars |
Fournisseurs de services de radiologie et d'oncologie
Partenariats de services spécialisés:
- Memorial Sloan Kettering Cancer Center
- MD Anderson Cancer Center
- Dana-Farber Cancer Institute
| Fournisseur | Portée du service | Durée du contrat | Valeur de partenariat annuelle |
|---|---|---|---|
| Memorial Sloan Kettering | Partage d'équipement en oncologie | 5 ans | 15,6 millions de dollars |
| MD Anderson | Services de radiothérapie | 3 ans | 11,2 millions de dollars |
| Dana-farber | Équipement de recherche sur le cancer | 4 ans | 9,7 millions de dollars |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: activités clés
Louer un équipement médical aux hôpitaux
AMS loue des équipements médicaux avec les mesures financières suivantes:
| Type d'équipement | Revenus de location annuelle | Nombre d'hôpitaux servis |
|---|---|---|
| Couteau gamma | 12,3 millions de dollars | 23 hôpitaux |
| Équipement d'oncologie de radiation | 8,7 millions de dollars | 17 hôpitaux |
Fournir des services de radiation d'oncologie
AMS Radiation Oncology Service Breakdown:
- Traitements totaux de radiothérapie en 2023: 4 562
- Revenu moyen par traitement: 3 450 $
- Couverture géographique: 12 États
Gérer la technologie des couteaux gamma
Détails de gestion de la technologie Gamma Knife:
| Paramètre technologique | Métrique opérationnelle |
|---|---|
| Unités totales de couteau gamma gérées | 14 unités |
| Coût de maintenance annuel par unité | $425,000 |
| Traitements des patients par unité | 328 par an |
Maintenir et entretenir un équipement médical
Statistiques des services de maintenance de l'équipement:
- Contrats de maintenance annuelle totale: 42
- Revenus de maintenance annuelle: 6,1 millions de dollars
- Valeur du contrat moyen: 145 238 $
Développer des solutions de technologie de santé stratégique
Métriques de développement de solutions technologiques:
| Catégorie de développement | Investissement | Personnel de R&D |
|---|---|---|
| Innovation de la technologie des soins de santé | 2,4 millions de dollars | 18 spécialistes |
| Développement de logiciels | 1,7 million de dollars | 12 ingénieurs |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: Ressources clés
Équipement médical avancé (technologie gamma au couteau)
En 2024, AMS exploite 5 unités de couteau Leksell Gamma à travers les États-Unis. L'investissement total dans la technologie des couteaux gamma est d'environ 25,4 millions de dollars. Chaque unité de couteau gamma a un coût de remplacement de 4,8 millions de dollars.
| Type d'équipement | Nombre d'unités | Investissement total | Par unité de coût |
|---|---|---|---|
| Couteau Leksell Gamma | 5 | 25,4 millions de dollars | 4,8 millions de dollars |
Infrastructure de services de santé spécialisée
AMS maintient 12 centres de radiochirurgie dédiés dans 8 États. L'investissement total des infrastructures est de 42,3 millions de dollars.
- Nombre total de centres de radiochirurgie: 12
- Couverture géographique: 8 États
- Investissement d'infrastructure: 42,3 millions de dollars
Expertise technique en technologie médicale
AMS emploie 87 professionnels spécialisés de la technologie médicale. L'expertise technique moyenne par l'employé est de 215 000 $.
| Catégorie professionnelle | Nombre d'employés | Investissement moyen par employé |
|---|---|---|
| Spécialistes de la technologie médicale | 87 | $215,000 |
Partenariats stratégiques avec les établissements de santé
AMS a établi des partenariats avec 23 grands réseaux de soins de santé. Les coûts totaux de développement de partenariat sont de 6,7 millions de dollars.
Personnel médical et technique formé
L'entreprise maintient un personnel de 214 membres du personnel médical et technique. L'investissement total de formation annuel est de 4,2 millions de dollars.
| Catégorie de personnel | Personnel total | Investissement de formation annuelle |
|---|---|---|
| Personnel médical et technique | 214 | 4,2 millions de dollars |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: propositions de valeur
Accès à l'équipement médical rentable pour les hôpitaux
AMS fournit des solutions de location d'équipements médicaux avec les mesures financières suivantes:
| Catégorie de location d'équipement | Revenus annuels | Part de marché |
|---|---|---|
| Équipement d'oncologie de radiation | 42,3 millions de dollars | 27.5% |
| Équipement d'imagerie diagnostique | 18,7 millions de dollars | 15.2% |
| Équipement chirurgical | 12,5 millions de dollars | 9.8% |
Technologies avancées de radiothérapie
Le portefeuille d'équipements technologiques AMS comprend:
- Systèmes de radiochirurgie robotique CyberKnife
- Unités de radiothérapie de précision du couteau gamma
- Systèmes d'accélérateur linéaire (LINAC)
Réduction des investissements en capital pour les établissements de santé
Impact financier des solutions de location AMS:
| Catégorie de réduction des investissements | Économies moyennes |
|---|---|
| Dépenses en capital initial | Réduction de 62% |
| Frais de maintenance | Réduction de 45% |
| Dépenses de mise à niveau technologique | Réduction de 38% |
Solutions de location d'équipements médicaux spécialisés
Segments de location AMS:
- Location d'équipement en oncologie
- Équipement d'imagerie diagnostique
- Location de technologie chirurgicale
Services de technologie médicale de haute qualité
Mesures de qualité du service:
| Indicateur de performance du service | Pourcentage |
|---|---|
| Time de disponibilité de l'équipement | 99.7% |
| Taux de satisfaction client | 94.5% |
| Temps de réponse technique du support | <4 heures |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: relations clients
Contrats de services à long terme avec les hôpitaux
AMS maintient 22 contrats de service à long terme actifs avec les établissements de santé en 2023. La durée moyenne du contrat est de 7,3 ans, une valeur de contrat annuelle variant de 1,2 million à 3,8 millions de dollars.
| Type de contrat | Nombre de contrats | Valeur annuelle moyenne |
|---|---|---|
| Équipement de radiologie | 12 | 2,5 millions de dollars |
| Radiation | 10 | 3,1 millions de dollars |
Contentement de support technique et de maintenance
AMS fournit un support technique complet couvrant 98,6% du cycle de vie de l'équipement. Le temps de réponse technique du support est en moyenne de 2,7 heures.
- Assistance technique d'urgence 24/7
- Entretien sur place dans les 4 heures
- Capacités de diagnostic à distance
Solutions de location d'équipements personnalisés
Portfolio de location d'équipement d'une valeur de 127,6 millions de dollars en 2023, avec 36 accords de location actifs dans 18 établissements de santé.
| Catégorie d'équipement | Accords de location | Valeur de location totale |
|---|---|---|
| Systèmes IRM | 14 | 62,3 millions de dollars |
| Accélérateurs linéaires | 22 | 65,3 millions de dollars |
Partenariats collaboratifs de technologie de santé
AMS maintient 7 partenariats technologiques stratégiques avec les fabricants d'équipements médicaux, représentant 43,2 millions de dollars en investissements en recherche et développement collaboratifs.
Engagement et consultation des clients en cours
Évaluation de satisfaction du client de 92,4% sur la base des enquêtes annuelles des clients. Événements annuels d'engagement client: 16 conférences régionales, 24 webinaires virtuels.
- Réunions de révision des performances trimestrielles
- Sommets annuels de l'innovation technologique
- Gestion de compte personnalisée
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: canaux
Équipe de vente directe
Depuis 2024, AMS maintient une équipe de vente directe de 37 représentants spécialisés des ventes d'équipements médicaux. Ventes annuelles moyennes par représentant: 1,2 million de dollars. Revenu total de l'équipe de vente directe: 44,4 millions de dollars.
| Métrique de l'équipe de vente | 2024 données |
|---|---|
| Représentants des ventes totales | 37 |
| Ventes annuelles moyennes par représentant | $1,200,000 |
| Revenus de ventes directes totaux | $44,400,000 |
Conférences de l'industrie des soins de santé
AMS participe à 18 conférences de soins de santé majeures chaque année. Diriges générés par la conférence: 426. Taux de conversion: 22,4%.
| Métrique de l'engagement de la conférence | 2024 données |
|---|---|
| Les conférences totales ont assisté | 18 |
| Total conférence Leads généré | 426 |
| Taux de conversion de plomb | 22.4% |
Salons des équipements médicaux
AMS présente 12 salons spécialisés en équipement médical en 2024. Investissement moyen par salon: 87 500 $. Investissement total des salons commerciaux: 1 050 000 $.
- Salons commerciaux présents: 12
- Investissement moyen par salon: 87 500 $
- Investissement total des salons commerciaux: 1 050 000 $
Plate-forme et site Web en ligne
Trafic de site Web d'AMS en 2024: 247 000 visiteurs uniques mensuels. Génération de leads en ligne: 1 340 pistes qualifiées par mois. Taux de conversion du site Web: 3,6%.
| Métrique de la plate-forme en ligne | 2024 données |
|---|---|
| Visiteurs de site Web unique mensuels | 247,000 |
| Leads en ligne qualifiés mensuels | 1,340 |
| Taux de conversion du site Web | 3.6% |
Références de réseaux médicaux professionnels
AMS reçoit 512 références de réseaux médicaux professionnels mensuellement. Taux de conversion de référence: 17,2%. Revenus générés par référence: 22,3 millions de dollars par an.
| Métrique de référence du réseau professionnel | 2024 données |
|---|---|
| Références professionnelles mensuelles | 512 |
| Taux de conversion de référence | 17.2% |
| Revenus de référence annuels | $22,300,000 |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: segments de clientèle
Hôpitaux régionaux
En 2024, AMS dessert environ 47 hôpitaux régionaux à travers les États-Unis. Ces hôpitaux représentent un segment de marché annuel d'une valeur de 128,6 millions de dollars pour l'AMS.
| Type d'hôpital | Numéro servi | Contribution annuelle des revenus |
|---|---|---|
| Hôpitaux régionaux communautaires | 32 | 87,3 millions de dollars |
| Hôpitaux régionaux ruraux | 15 | 41,3 millions de dollars |
Centres de traitement du cancer
AMS fournit des services spécialisés à 23 centres de traitement du cancer dédiés à l'échelle nationale, générant 92,4 millions de dollars de revenus annuels.
- Centres de cancer complets: 12
- Centres de cancer communautaire: 11
Institutions de recherche médicale
La société soutient 18 établissements de recherche médicale avec des technologies de diagnostic et de traitement spécialisées, ce qui représente 64,7 millions de dollars en revenus de segments annuels.
| Type d'institution de recherche | Numéro servi | Revenus annuels |
|---|---|---|
| Centres de recherche affiliés à l'université | 9 | 37,2 millions de dollars |
| Institutions de recherche indépendantes | 9 | 27,5 millions de dollars |
Réseaux de soins de santé privés
AMS dessert 35 réseaux de soins de santé privés, générant 156,9 millions de dollars de revenus annuels.
- Réseaux de soins de santé multi-États: 22
- Réseaux privés régionaux: 13
Centres médicaux académiques
La société fournit des services à 16 centres médicaux universitaires, ce qui contribue 89,5 millions de dollars aux revenus annuels.
| Classification du centre | Nombre de centres | Contribution annuelle des revenus |
|---|---|---|
| Universités de recherche de haut niveau | 8 | 52,3 millions de dollars |
| Centres médicaux académiques régionaux | 8 | 37,2 millions de dollars |
Services hospitaliers partagés américains (AMS) - Modèle d'entreprise: Structure des coûts
Procurement et entretien de l'équipement
Coûts de l'approvisionnement en équipement annuel: 12,4 millions de dollars en 2023
| Catégorie d'équipement | Coût de maintenance annuel |
|---|---|
| Équipement IRM | 3,2 millions de dollars |
| Systèmes de radiothérapie | 2,7 millions de dollars |
| Machines d'imagerie diagnostique | 2,5 millions de dollars |
Salaires du personnel technique
Total des dépenses de salaire du personnel technique annuel: 18,6 millions de dollars en 2023
- Salaire moyen du personnel technique: 95 000 $ par an
- HeadCount de personnel technique total: 196 employés
- Techniciens radiologiques spécialisés Salaire moyen: 112 500 $
Investissements de recherche et développement
Dépenses totales de R&D: 4,3 millions de dollars en 2023
| Zone de focus R&D | Montant d'investissement |
|---|---|
| Technologies d'imagerie avancées | 2,1 millions de dollars |
| Innovations de radiation en oncologie | 1,5 million de dollars |
| Intégration de la santé numérique | $700,000 |
Frais de marketing et de vente
Budget total de marketing et de vente: 3,7 millions de dollars en 2023
- Dépenses en marketing numérique: 1,2 million de dollars
- Parrainages de la conférence des soins de santé: 850 000 $
- Compensation de l'équipe de vente: 1,65 million de dollars
Coûts d'infrastructure opérationnelle
Total des dépenses d'infrastructure opérationnelle: 6,9 millions de dollars en 2023
| Composant d'infrastructure | Coût annuel |
|---|---|
| Baux des installations | 3,2 millions de dollars |
| Infrastructure informatique | 1,8 million de dollars |
| Services publics et maintenance | 1,9 million de dollars |
Services hospitaliers partagés américains (AMS) - Modèle commercial: sources de revenus
Frais de location d'équipement médical
Depuis 2023 Exercice, AMS a déclaré des revenus de location d'équipements médicaux de 17,4 millions de dollars. La société loue un équipement médical spécialisé dans des établissements de santé dans plusieurs États.
| Type d'équipement | Revenus de location annuelle | Nombre d'unités louées |
|---|---|---|
| Couteau gamma | 8,2 millions de dollars | 12 unités |
| Équipement de radiothérapie | 6,5 millions de dollars | 9 unités |
| Autres équipements médicaux spécialisés | 2,7 millions de dollars | 5 unités |
Frais de service d'oncologie radiographique
En 2023, les frais de service de radiation en oncologie ont généré 22,6 millions de dollars de revenus pour AMS.
- Frais de service moyen par patient: 3 750 $
- Les patients totaux ont servi: 6 037
- Couverture géographique: 14 États
Contrats de maintenance technologique
Les revenus du contrat de maintenance technologique ont atteint 9,3 millions de dollars en 2023.
| Type de contrat | Revenus annuels | Nombre de contrats |
|---|---|---|
| Entretien complet | 6,1 millions de dollars | 87 contrats |
| Maintenance de base | 3,2 millions de dollars | 112 contrats |
Gamma Knife Technology Service Revenue
Gamma Knife Technology Services a généré 15,7 millions de dollars en 2023.
- Nombre de centres de couteaux gamma soutenus: 22
- Revenu moyen par centre: 714 000 $
- Volume de procédure: 4 256 traitements
Services de conseil et de support technique
Les services de conseil et de support technique ont contribué 5,2 millions de dollars aux revenus AMS en 2023.
| Catégorie de service | Revenus annuels | Taux horaire moyen |
|---|---|---|
| Conseil technique | 3,6 millions de dollars | 275 $ / heure |
| Services de formation | 1,6 million de dollars | 195 $ / heure |
American Shared Hospital Services (AMS) - Canvas Business Model: Value Propositions
You're looking at how American Shared Hospital Services (AMS) delivers distinct value to its partners and patients as of late 2025. The core proposition centers on de-risking and enabling access to capital-intensive cancer treatment modalities.
Access to Advanced Technology Without Upfront Capital Strain
American Shared Hospital Services (AMS) provides hospitals and health systems access to high-cost cancer technology, like their Gamma Knife systems, without requiring them to shoulder the massive initial capital outlay. This model is evident in the revenue mix. For the first nine months of 2025, revenue from the equipment leasing segment was $9.7 million, contrasting with the $10.7 million generated by the direct patient care services segment over the same period. This shows the dual approach in action, where leasing alleviates capital burdens for partners, while direct care captures higher margin service revenue.
The value proposition is also about enabling the adoption of specific, high-precision tools. For instance, while Gamma Knife revenue for the first nine months of 2025 was $6.8 million, the company continues to invest in and deploy these systems, such as planning for a new Esprit installation in Guadalajara, Mexico, expected to start up in the second quarter of 2026.
Flexible Business Model: Leasing Versus Direct Care
The flexibility of the business model is a key differentiator, allowing American Shared Hospital Services (AMS) to serve different partner needs. You see this flexibility reflected in the shift of revenue contribution between the segments.
| Segment | Q3 2025 Revenue Share | 9M 2025 Revenue (Millions USD) |
| Direct Patient Care Services | 56% | $10.7 million |
| Equipment Leasing | 44% (Implied) | $9.7 million |
The direct patient services segment is clearly gaining traction, increasing its share from 53% last year to 56% in Q3 2025. This segment saw revenue jump 36.5% year-over-year for the first nine months of 2025, reaching $10.7 million from $7.8 million in the prior year.
Operational Expertise Maximizing Utilization
Operational expertise translates directly into better financial performance when volumes increase. The focus on maximizing utilization is supported by the improved gross margin, which reached 22.1% in Q3 2025, marking a 15.8% increase period over period. This margin improvement was explicitly driven by higher treatment volumes. Furthermore, the operational leverage is clear in the EBITDA growth; Q3 2025 EBITDA was $1.94 million, a 42.3% increase over Q3 2024's $1.37 million. The new radiation therapy center in Puebla, Mexico, exemplifies this, showing revenue growth of 263% in Q3 2025 off a small base, proving the model's ability to ramp up new centers effectively.
High-Precision Modalities
American Shared Hospital Services (AMS) delivers value through specialized, high-precision modalities like stereotactic radiosurgery and advanced radiation therapy. The company's Q3 2025 results highlighted increased revenue from direct patient care services, which includes these advanced treatments. The growth in the direct patient services segment, up 9.4% in Q3 2025, is tied to increased procedures at new U.S. centers in Rhode Island and the new facility in Puebla, Mexico. For context on the scale of technology deployment, in the full year 2024, their proton therapy segment recorded 5,139 treatments.
- Q3 2025 Net Loss decreased by 91.8% to a loss of $17,000 from a loss of $207,000 in Q3 2024.
- For the nine months ended September 30, 2025, total revenue was $20.4 million.
- The company is expanding its U.S. footprint, with permitting underway for a fourth radiation therapy center in Bristol, Rhode Island.
American Shared Hospital Services (AMS) - Canvas Business Model: Customer Relationships
American Shared Hospital Services (AMS) maintains long-term, high-touch relationships with health system partners, a critical component given the nature of advanced radiation therapy services.
The emphasis on human interaction is supported by broader healthcare trends; for instance, in late 2025 surveys, 89% of people indicated they prefer to speak to a real person over an AI when contacting a healthcare practice. This underscores the value of the personal connection AMS provides in its direct patient care model.
The relationship structure often involves joint venture structures for shared risk and reward. Specific health system partners mentioned include Care New England and Prospect CharterCare. A concrete example of this shared commitment is the recent signing of a 10-year extension with an existing health system, which also included an upgrade to their Gamma Knife system.
The shift in focus is evident in the revenue mix, demonstrating a move toward deeper integration through direct patient interaction and care management at owned centers.
| Metric | Q3 2025 Value | Year-over-Year Change |
| Direct Patient Services Revenue (Q3 2025) | $4.0 million | 9.4% increase |
| Direct Patient Services Revenue (First Nine Months 2025) | $10.7 million | 36.5% increase |
| Direct Patient Services Revenue as % of Total Sales (Q3 2025) | 56% | Up from 53% in prior year period |
| Equipment Leasing Revenue (Q3 2025) | $3.1 million | Decreased 5.3% |
This growth in direct care is fueled by operations like the new centers in Puebla, Mexico, and the ramp-up in Rhode Island.
The focus is definitely on securing contract extensions and upgrades to ensure revenue visibility and continued partnership. While a 10-year extension was recently secured, the equipment leasing segment revenue was negatively impacted by the expiration of three customer contracts since the fourth quarter of 2024.
Key relationship activities and outcomes include:
- Securing a 10-year extension with an existing health system partner.
- Executing an upgrade to their Gamma Knife system as part of a partnership agreement.
- Managing the impact of three expired customer contracts in the leasing segment since Q4 2024.
- Growing direct patient care revenue by 36.5% for the first nine months of 2025 to $10.7 million.
Finance: draft 13-week cash view by Friday.
American Shared Hospital Services (AMS) - Canvas Business Model: Channels
You're looking at how American Shared Hospital Services (AMS) gets its services and equipment to the market as of late 2025. The Channels block shows a clear pivot, moving from a primary leasing model to one where direct patient care is the main revenue driver. This shift is executed through physical centers and direct sales efforts targeting executive decision-makers in health systems.
The core of the channel strategy is twofold: owning and operating treatment centers, and maintaining a legacy, though shrinking, equipment leasing business. The direct patient care segment is definitely where the near-term momentum is, evidenced by the financial results from the third quarter ended September 30, 2025. Honestly, the numbers tell you where the focus is right now.
Here's a quick look at how the two main revenue-generating channels performed for the first nine months of 2025 compared to the same period in 2024:
| Channel Metric | Nine Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2024 | Change |
| Direct Patient Care Revenue | $10.7 million | $7.8 million | Up 36.5% |
| Equipment Leasing Revenue | $9.7 million | $11.5 million | Decreased |
| Direct Patient Care Revenue Share | 56% (Q3 2025) | 53% (Q3 2024) | Increased Share |
The direct-owned and operated radiation therapy treatment centers are clearly the growth engine. You see this in the revenue figures, but also in the geographic expansion. The new center in Puebla, Mexico, is off to a fantastic start, with revenues growing by 263% off a small base in the period leading up to Q3 2025. Also, the Rhode Island operations, including the new physicians ramping up, are contributing heavily to this segment's success. The company is actively building out this channel, with Certificate of Need approvals secured for a radiation therapy center in Bristol, Rhode Island, and a proton beam center in Johnston, Rhode Island, further expanding the domestic footprint.
The equipment leasing agreements directly with hospitals and clinics still form a significant part of the business, though it's contracting. Revenue from this segment was $3.1 million for Q3 2025, a decrease of 5.3% compared to the prior year period. This dip is attributed to lower Proton Beam Radiation Therapy (PBRT) volumes and the expiration of three customer contracts since the fourth quarter of 2024. Still, the business development team is working to secure the future of this channel; they recently signed an Existing Health System to a 10 Year Extension for an Esprit-the latest model Gamma Knife System.
The business development and sales team targeting health system executives is the mechanism that drives both the leasing extensions and the development of new direct-care centers. Their success is measured by securing long-term contracts and new market entries. For instance, the team is executing on the pipeline that includes a new Gamma Knife center in Guadalajara, Mexico, which is expected to start up in the second quarter of 2026. This team is key to translating strategic approvals into operational revenue streams.
The channel strategy is supported by specific operational metrics:
- - Gamma Knife procedures in Q3 2025 were 231, up from 218 in Q3 2024.
- - Linear accelerator (Linac) systems revenue was $2.9 million for Q3 2025, up 51.2% compared to Q3 2024, driven by the Puebla, Mexico launch and staffing in Rhode Island.
- - Capital expenditures of $7.5 million were spent through September 30, 2025, for projects including Peru, Bristol, Rhode Island, and Northwestchester, which directly fund the physical channel expansion.
Finance: draft 13-week cash view by Friday.
American Shared Hospital Services (AMS) - Canvas Business Model: Customer Segments
You're looking at the customer base for American Shared Hospital Services (AMS) as of late 2025. The focus is clearly shifting, with direct patient care now driving a larger piece of the revenue pie.
The customer segments American Shared Hospital Services serves can be broken down by their relationship with the company's two main operating segments: equipment leasing and direct patient care services.
- US and international health systems seeking advanced cancer technology.
- Cancer treatment centers requiring Gamma Knife or PBRT equipment.
- Direct cancer patients in regions with AMS-operated clinics.
- Physicians and oncologists referring patients to AMS centers.
The health systems segment, which involves equipment leasing, saw its revenue dip in the third quarter of 2025. Revenue from this segment was $3.1 million for Q3 2025, reflecting a 5.3% decrease compared to the prior year period, largely due to lower Proton Beam Radiation Therapy (PBRT) volumes. For the first nine months of 2025, leasing revenue was $9.7 million, down from $11.5 million for the same period in 2024. Still, a key relationship was solidified with the signing of a 10-year extension for a Gamma Knife System upgrade with an existing health system.
For centers specifically needing advanced equipment, the Gamma Knife revenue component for the first nine months of 2025 was $6.8 million, a 4.2% decline from the $7.1 million reported in the first nine months of 2024. This highlights the variability in equipment utilization across the customer base.
| Customer Segment Indicator | Q3 2025 Financial Metric | Nine Months 2025 Financial Metric |
| Direct Patient Services Revenue | $4.0 million | $10.7 million |
| Equipment Leasing Revenue | $3.1 million | $9.7 million |
| Direct Patient Services % of Total Sales | 56% | N/A |
The direct cancer patients segment, served through American Shared Hospital Services-operated clinics, is showing strong momentum. Revenue from direct patient services in Q3 2025 was $4.0 million, marking a 9.4% increase period over period. This segment accounted for 56% of total sales in Q3 2025, up from 53% in the prior year period. The nine-month revenue for this segment reached $10.7 million, a 36.5% increase over the $7.8 million from the first nine months of 2024. This growth is heavily influenced by the new radiation therapy center in Puebla, Mexico, which is off to a fantastic start, and ramping volumes from new physicians in Rhode Island.
Physicians and oncologists act as key referrers, directly impacting the direct patient services revenue. The growth in this area suggests strong referral patterns, especially given the expansion into new US markets like Bristol and Johnston, Rhode Island, where Certificate of Need approvals were secured. Furthermore, American Shared Hospital Services is planning for future patient volume with the expected startup of a new Esprit Gamma Knife center in Guadalajara, Mexico, in the second quarter of 2026.
- Direct Patient Services Revenue Growth (Q3 2025 vs. Q3 2024): 9.4%
- Direct Patient Services Revenue Growth (Nine Months 2025 vs. Nine Months 2024): 36.5%
- New US Locations with Approved Centers: 2 (Bristol and Johnston, Rhode Island)
- International Center Driving Growth: Puebla, Mexico
Finance: draft 13-week cash view by Friday.
American Shared Hospital Services (AMS) - Canvas Business Model: Cost Structure
You're looking at the cost drivers for American Shared Hospital Services (AMS) as of late 2025, and honestly, it's a capital-intensive business, which means big upfront and ongoing costs for the high-tech gear they use.
The structure is clearly weighted toward fixed and semi-fixed expenses tied to their advanced radiation therapy equipment, like Gamma Knife systems. While I don't have the exact depreciation schedule, the cash flow impact from new asset acquisition is clear.
- - High fixed costs for equipment depreciation and maintenance.
- - Significant capital expenditures, totaling $7.5 million in 9M 2025.
- - Personnel costs for specialized clinical and technical staff.
- - Operating costs for direct patient care centers (e.g., utilities, supplies).
The capital deployment is a major cost component you need to track. For the first nine months of 2025, American Shared Hospital Services spent $7.5 million on capital expenditures, covering locations like Peru, Bristol, Rhode Island, and Northwestchester. This spending directly feeds into future depreciation expenses, which are a core fixed cost.
The shift in business mix also impacts the cost profile. As direct patient care services grow-accounting for 56% of total sales in Q3 2025-the nature of operating costs changes. The equipment leasing segment, which historically carried higher margins, is seeing revenue decline due to contract expirations. This shift to direct care, while driving revenue growth, comes with lower margins compared to leasing.
Here's a look at the key financial metrics that reflect these costs for the first nine months of 2025:
| Cost/Revenue Metric | Amount (9M 2025) | Context |
| Total Revenue | $20.4 million | Year-over-year increase of 5.6% |
| Gross Margin Amount | $4.2 million | Down from $6.0 million in 9M 2024 |
| Gross Margin Percentage | 20.4% | Reflects lower margins from the shift to direct patient services |
| Capital Expenditures (CapEx) | $7.5 million | Drove cash down from $11.3 million (Dec 31, 2024) to $5.3 million (Sept 30, 2025) |
Personnel costs, covering specialized clinical and technical staff necessary to operate Gamma Knife and other advanced systems, represent a significant, likely high, variable cost within the direct patient care segment. You see the pressure on margins because of this shift; for the nine months ended September 30, 2025, the gross margin was 20.4%, down from $6.0 million in the prior year period. This decline is explicitly attributed to lower treatment volumes in leasing and increased operating costs driven by the direct patient care segment.
To be fair, the company is managing its operating expenses well enough to see Adjusted EBITDA grow to $4.6 million for the nine months ended September 30, 2025, up from $5.1 million in the first nine months of 2024. Still, the net loss for the nine months was $0.9 million. Finance: draft 13-week cash view by Friday.
American Shared Hospital Services (AMS) - Canvas Business Model: Revenue Streams
You're analyzing the revenue streams for American Shared Hospital Services (AMS) as of late 2025, and the numbers clearly show a business in transition, moving away from pure equipment leasing toward direct service delivery. This shift is the defining characteristic of their current revenue profile.
The total top-line performance for the first nine months of 2025 demonstrates growth, driven by the expansion of their patient care footprint. For the first nine months of 2025, American Shared Hospital Services reported a total revenue of $20.4 million.
This total revenue is sourced from two primary, distinct segments, reflecting the dual nature of their business model:
- - Direct patient care services revenue, which grew to $10.7 million in 9M 2025.
- - Equipment leasing revenue, which was $9.7 million in 9M 2025.
- - Service and maintenance fees from leased equipment contracts.
- - Total revenue for the first nine months of 2025 was $20.4 million.
Here's the quick math on how those two main components combine to form the nine-month total: $10.7 million plus $9.7 million equals $20.4 million. This shows that the direct patient care segment is now the larger contributor to revenue, accounting for approximately 52.45% of the total for the nine-month period ($10.7M / $20.4M).
To give you a clearer picture of the segment performance for the nine months ended September 30, 2025, compared to the prior year period, look at this breakdown:
| Revenue Stream Component | Revenue (9M 2025) | Revenue (9M 2024) |
| Direct Patient Care Services Revenue | $10.7 million | $7.8 million |
| Equipment Leasing Revenue | $9.7 million | $11.5 million |
| Total Revenue | $20.4 million | $19.3 million |
The trend within these streams is telling. Direct patient care revenue saw a substantial year-over-year increase of 36.5% ($10.7M vs $7.8M), clearly indicating successful execution of their strategy, likely driven by new centers in Rhode Island and Puebla, Mexico. Conversely, the equipment leasing revenue declined to $9.7 million from $11.5 million in the first nine months of 2024, a drop of about 15.65%, which management attributes to lower Gamma Knife volumes and expired customer contracts. This decline in the legacy stream is being offset by the growth in the newer patient-centric model.
The composition of the revenue streams is also reflected in the quarterly performance, showing the acceleration of the shift:
- Q3 2025 Direct Patient Services Revenue: $4.0 million.
- Q3 2025 Total Revenue: $7.2 million.
- Percentage of Total Sales from Direct Patient Care (Q3 2025): 56%.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.